Barriers and facilitators for the safe handling of antineoplastic drugs.
Sajjad S FazelAnya KeefeArshiya ShareefAlison L PalmerDarren R BrennerLynne NakashimaMieke W KoehoornChris B McLeodAmy L HallCheryl E PetersPublished in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2021)
The combination of barriers and facilitators identified in our review highlight the importance of creating work environments where safety is a priority for the safe handling of antineoplastic drugs. The results of this study will assist policy makers and managers in identifying gaps and enhancing strategies that reduce occupational exposure to antineoplastic drugs.